The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Target Validation, 2014Validating BAG5 as a Therapeutic Target of Parkinson’s Disease
Objective/Rationale:
Poor handling and elimination of misfolded proteins has been identified as central in the development of Parkinson’s disease (PD). A special class of proteins within the cell... -
Target Validation, 2012Validation of Sirtuin 3 as a Neuroprotective Target in Parkinson’s Disease
Objective/Rationale:
Mitochondria are the major energy generators of a cell. Dysfunctional mitochondria are central to the pathology of Parkinson’s Disease (PD). We hypothesize that improving the... -
Research Grant, 2021Changing Rhythms in Parkinson’s Disease: Development of Motor and Non-motor Markers of Progression Based on Continuous Daily Monitoring
Study Rationale: Although new treatments are being developed to slow the progression of Parkinson’s disease (PD), assessing their effectiveness remains a challenge. Standard evaluations, conducted in...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.